However, the overall effect of adiponectin and leptin are not clear, with a meta-analysis showing no significant risk from leptin for CRC, and the risk associated with adiponectin varies based on patient weight and gender (Wang et al., 2021[115]). Here, ADIPOQ is linked to colorectal carcinoma.